Second IASLC Workshop on combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Treatment evaluation.
dc.contributor.author | Hansen, H | |
dc.contributor.author | Perry, M | |
dc.contributor.author | Arriagada, R | |
dc.contributor.author | Chastang, C | |
dc.contributor.author | Drings, P | |
dc.contributor.author | Osterlind, K | |
dc.contributor.author | Parmar, M | |
dc.contributor.author | Pignon, J P | |
dc.contributor.author | Thatcher, Nick | |
dc.date.accessioned | 2010-04-23T11:39:36Z | |
dc.date.available | 2010-04-23T11:39:36Z | |
dc.date.issued | 1994-03 | |
dc.identifier.citation | Second IASLC Workshop on combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Treatment evaluation. 1994, 10 Suppl 1:S7-9 Lung Cancer | en |
dc.identifier.issn | 0169-5002 | |
dc.identifier.pmid | 8087529 | |
dc.identifier.doi | 10.1016/0169-5002(94)91660-8 | |
dc.identifier.uri | http://hdl.handle.net/10541/97292 | |
dc.language.iso | en | en |
dc.subject | Lung Cancer | en |
dc.subject | Cancer Staging | en |
dc.subject.mesh | Clinical Trials as Topic | |
dc.subject.mesh | Clinical Trials, Phase II as Topic | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Lung Neoplasms | |
dc.subject.mesh | Meta-Analysis as Topic | |
dc.subject.mesh | Neoplasm Staging | |
dc.subject.mesh | Outcome Assessment (Health Care) | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Randomized Controlled Trials as Topic | |
dc.subject.mesh | Registries | |
dc.subject.mesh | Survival Analysis | |
dc.subject.mesh | Treatment Outcome | |
dc.title | Second IASLC Workshop on combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Treatment evaluation. | en |
dc.type | Article | en |
dc.identifier.journal | Lung Cancer | en |